Articles in IPOs

Renaissance Capital

Get pumped: Insulin pump maker Asante Solutions files for a $45 million IPO

Asante Solutions, which markets a recently approved insulin pump system with pre filled cartridges, filed on Friday with the SEC to raise up to $45 million in an initial public offering. The... Read >>

Renaissance Capital

Reverse Mortgage Investment Trust files for a $100 million IPO

Reverse Mortgage Investment Trust, a REIT recently formed to originate, service and invest in reverse mortgage loans, filed on Friday with the SEC to raise up to $100 million in an initial public... Read >>

Renaissance Capital

Chinese brick maker Yulong Eco-Materials files for a $100 million IPO

Yulong Eco Materials, a Chinese producer of fly ash bricks and concrete used in commercial and residential construction, filed on Friday with the SEC to raise up to $100 million in an initial... Read >>

Renaissance Capital

REIT Power: InfraREIT files for a $400 million IPO

InfraREIT, a REIT formed to own electric transmission and distribution assets in Texas, filed on Friday with the SEC to raise up to $400 million in an initial public offering. The Dallas, TX based... Read >>

Renaissance Capital

US IPO Weekly Recap: Record 2014 IPO market finishes with a $2 billion cancer biotech

Four companies went public in the past week and brought the final IPO count of 2014 up to 275 deals that raised $85 billion, making it the most active year for the IPO market since 2000. The... Read >>

Renaissance Capital

Renaissance IPO ETFs - Notice of Quarterly Distributions

Renaissance Capital announces the declaration of the quarterly distributions for the Renaissance IPO ETFs. The Renaissance IPO ETF (Ticker IPO) will pay a distribution of $0.5990 per share for the... Read >>

Renaissance Capital

Juno Therapeutics prices upsized IPO at $24; largest 2014 biotech IPO with $2.2 billion market cap

Juno Therapeutics, which is developing T cell therapies for lymphomas, leukemias and other cancers, raised $265 million by offering 11 million shares (all primary) at $24, above the range of $21... Read >>

Renaissance Capital

Growth hormone biotech Ascendis Pharma files for a $86 million IPO

Ascendis Pharma, which is developing long acting treatments for growth hormone deficiency, filed on Thursday with the SEC to raise up to $86 million in an initial public offering. Close peer... Read >>

Renaissance Capital

Blackstone-backed Summit Materials files for a $100 million IPO

Summit Materials, a Blackstone backed aggregates, cement and concrete US supplier, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The $100 million deal... Read >>

Renaissance Capital

First Guaranty Bancshares postpones IPO

First Guaranty Bancshares, a Louisiana bank with 21 branches and $1.5 billion in assets, postponed its IPO on Thursday. The Hammond, LA based company, listed on the OTC, was founded in 1934 and... Read >>

Displaying 1-10 of 3005
<< first < previous 1 2 3 4 5 50 100 150 200 250 300 last >>